- A Bimetallic Metal–Organic Framework Encapsulated with DNAzyme for Intracellular Drug Synthesis and Self-Sufficient Gene Therapy
-
Although chemotherapy is one of the most widely used cancer treatments, there are serious side effects, drug resistance, and secondary metastasis. To address these problems, herein we designed a bimetallic metal–organic framework (MOF) encapsulated with DNAzyme for co-triggered in situ cancer drug synthesis and DNAzyme-based gene therapy. Once in cancer cells, MOFs would disassemble and liberate copper ions, zinc ions, and DNAzyme under the acidic environment of lysosomes. Copper ions can catalyze the synthesis of the chemotherapeutic drug through copper-catalyzed azide–alkyne cycloaddition (CuAAC) reaction after being reduced to CuI; zinc ions act as the cofactor to activate the cleavage activity of DNAzyme. The anticancer drug is synthesized intracellularly and can kill cancer cells on site to minimize side effects to normal organisms. The activated DNAzyme starts gene therapy to inhibit tumor proliferation and metastasis by targeting and cleaving oncogene substrates.
- Wang, Zhao,Niu, Jingsheng,Zhao, Chuanqi,Wang, Xiaohui,Ren, Jinsong,Qu, Xiaogang
-
supporting information
p. 12431 - 12437
(2021/04/30)
-
- Synthesis and initial biological evaluation of myxocoumarin B
-
The myxocoumarins A and B from Stigmatella aurantiaca MYX-030 are natural products featuring unusual nitro- and long-chain alkyl substitution. While myxocoumarin A was shown to exhibit strong antifungal properties, the antifungal potential of myxocoumarin
- Müller, Jonas I.,Kusserow, Kalina,Hertrampf, Gesa,Pavic, Aleksandar,Nikodinovic-Runic, Jasmina,Gulder, Tobias A. M.
-
supporting information
p. 1966 - 1969
(2019/02/20)
-
- A Biocompatible Heterogeneous MOF–Cu Catalyst for In Vivo Drug Synthesis in Targeted Subcellular Organelles
-
As a typical bioorthogonal reaction, the copper-catalyzed azide–alkyne cycloaddition (CuAAC) has been used for drug design and synthesis. However, for localized drug synthesis, it is important to be able to determine where the CuAAC reaction occurs in living cells. In this study, we constructed a heterogeneous copper catalyst on a metal–organic framework that could preferentially accumulate in the mitochondria of living cells. Our system enabled the localized synthesis of drugs through a site-specific CuAAC reaction in mitochondria with good biocompatibility. Importantly, the subcellular catalytic process for localized drug synthesis avoided the problems of the delivery and distribution of toxic molecules. In vivo tumor therapy experiments indicated that the localized synthesis of resveratrol-derived drugs led to greater antitumor efficacy and minimized side effects usually associated with drug delivery and distribution.
- Wang, Faming,Zhang, Yan,Liu, Zhengwei,Du, Zhi,Zhang, Lu,Ren, Jinsong,Qu, Xiaogang
-
supporting information
p. 6987 - 6992
(2019/04/14)
-
- SUBSTITUTED AROMATIC COMPOUND, HYDROGELATION AGENT, HYDROGEL, AND METHOD FOR GELATING AQUEOUS SAMPLE
-
According to the present invention, a substituted aromatic compound represented by the following general formula (I) is provided. In general formula (I), A1, A2, and A3 each independently represent an aryl group substituted by a hydrophilic group.
- -
-
Paragraph 0159; 0160; 0161
(2014/01/23)
-
- Synthesis and biological activity of C-4 and C-15 Aryl azide derivatives of anguidine
-
Potential trichothecene photoaffinity reagents were prepared by coupling either the C-4 or C-15 alcohols derived from anguidine with (3-azido-5-methoxyphenoxy) acetic acid, 4-(3-azido-5-methoxyphenoxy)butyric acid, or N-(3-azido-5-methoxyphenyl) N'-(carbo
- Richardson, Stewart K.,Jeganathan, Alwarsamy,Mani, Rajarathnam S.,Haley, Boyd E.,Watt, David S.,Trusal, Lynn R.
-
p. 2925 - 2934
(2007/10/02)
-